JTK-853

Star0

DB13095InvestigationalSmall molecule

JTK-853 has been used in trials studying the treatment of Hepatitis C Virus Infection, Response to Therapy of.

Formula / weight: C₂₈H₂₃F₇N₆O₄S₂ · 704.639 g/mol (avg)
Code names: JTK-853

Resolves to

Compound

UNIIWDX8QQD13BCAS954389-09-4PubChem57519700

Structure

InChIKeyJQLOVYLALGSISI-HXUWFJFHSA-NSMILESFC1=C(OC(F)(F)F)C=CC(CNC(=O)[C@H]2CN(CCN2S(=O)(=O)C2=CC=C(C=C2)C(F)(F)F)C2=NC3=C(S2)C=NC(=N3)C2CC2)=C1

Targets

P26664Genome polyprotein

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with JTK-853, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account